Reuters logo
BRIEF-ObsEva starts key study testing nolasiban in ART
March 7, 2017 / 12:41 PM / 7 months ago

BRIEF-ObsEva starts key study testing nolasiban in ART

March 7 (Reuters) - ObsEva SA

* Obseva starts phase 3 clinical program for nolasiban in art

* Obseva sa -initiation of phase 3 clinical program evaluating efficacy,safety of nolasiban to improve pregnancy,live birth rates in women undergoing art Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below